Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$26.74 -0.59 (-2.16%)
As of: Sep 29, 2026 · 3:59 PM EDT

Arcutis Biotherapeutics (ARQT) Research & Development (2019 - 2026)

Updated

Arcutis Biotherapeutics' Research & Development came in at $20.36 million for Q2 2026, up 4.6% from $19.45 million a year earlier but down 33.5% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Research & Development (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Arcutis Biotherapeutics reported Research & Development of $91.04 million, up 28.3% year-over-year; for FY2025, it came in at $77.05 million, up 0.8% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
  • Going back by year, Research & Development was $76.42 million in FY2024 (-30.9%), $110.58 million in FY2023 (-39.4%), $182.44 million in FY2022 (+25.3%) and $145.56 million in FY2021 (+26.2%).
  • The five-year range for quarterly Research & Development is $14.48 million (Q4 2024) to $69.73 million (Q3 2022).
  • Year-over-year, Research & Development has increased for five consecutive quarters, with growth averaging 4.1% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 92.0%), and the weakest in Q3 2023 (a decline of 62.4%).
  • Business Quant data shows ARQT's Research & Development at $30.63 million (Q1 2026), $20.45 million (Q4 2025) and $19.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Arcutis Biotherapeutics 3.43 Bn 2.72 Bn 118.92 Mn 20.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.36 Mn
Mar 31, 2026 30.63 Mn
Dec 31, 2025 20.45 Mn
Sep 30, 2025 19.60 Mn
Jun 30, 2025 19.45 Mn
Mar 31, 2025 17.54 Mn
Dec 31, 2024 14.48 Mn
Sep 30, 2024 19.50 Mn
Jun 30, 2024 19.30 Mn
Mar 31, 2024 23.14 Mn
Dec 31, 2023 23.78 Mn
Sep 30, 2023 26.24 Mn
Jun 30, 2023 25.22 Mn
Mar 31, 2023 35.35 Mn
Dec 31, 2022 33.88 Mn
Sep 30, 2022 69.73 Mn
Jun 30, 2022 38.21 Mn
Mar 31, 2022 40.62 Mn
Dec 31, 2021 52.56 Mn
Sep 30, 2021 40.60 Mn
API Access

Arcutis Biotherapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ARQT&period=max&api_key=YOUR_API_KEY